133 related articles for article (PubMed ID: 2007364)
1. Pilot study of sandostatin (octreotide) therapy of refractory HIV-associated diarrhea.
Fanning M; Monte M; Sutherland LR; Broadhead M; Murphy GF; Harris AG
Dig Dis Sci; 1991 Apr; 36(4):476-80. PubMed ID: 2007364
[TBL] [Abstract][Full Text] [Related]
2. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
Topkan E; Karaoglu A
Oncology; 2006; 71(5-6):354-60. PubMed ID: 17873499
[TBL] [Abstract][Full Text] [Related]
3. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial.
Cello JP; Grendell JH; Basuk P; Simon D; Weiss L; Wittner M; Rood RP; Wilcox CM; Forsmark CE; Read AE
Ann Intern Med; 1991 Nov; 115(9):705-10. PubMed ID: 1929038
[TBL] [Abstract][Full Text] [Related]
4. Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial.
Garcia Compean D; Ramos Jimenez J; Guzman de la Garza F; Saenz C; Maldonado H; Barragan RF; Michel H
AIDS; 1994 Nov; 8(11):1563-7. PubMed ID: 7848592
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of octreotide in the management of chronic diarrhoea in AIDS.
Romeu J; Miró JM; Sirera G; Mallolas J; Arnal J; Valls ME; Tortosa F; Clotet B; Foz M
AIDS; 1991 Dec; 5(12):1495-9. PubMed ID: 1814331
[TBL] [Abstract][Full Text] [Related]
6. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea.
Simon DM; Cello JP; Valenzuela J; Levy R; Dickerson G; Goodgame R; Brown M; Lyche K; Fessel WJ; Grendell J
Gastroenterology; 1995 Jun; 108(6):1753-60. PubMed ID: 7768380
[TBL] [Abstract][Full Text] [Related]
7. Octreotide treatment in secretory and cyrptosporidial diarrhea in patients with acquired immunodeficiency syndrome (AIDS): clinical evaluation.
Liberti A; Bisogno A; Izzo E
J Chemother; 1992 Oct; 4(5):303-5. PubMed ID: 1479420
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of the somatostatin analog octreotide acetate in the treatment of fluoropyrimidine-induced diarrhea.
Wadler S; Haynes H; Wiernik PH
J Clin Oncol; 1995 Jan; 13(1):222-6. PubMed ID: 7799023
[TBL] [Abstract][Full Text] [Related]
9. Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma.
Petrelli NJ; Rodriguez-Bigas M; Rustum Y; Herrera L; Creaven P
Cancer; 1993 Sep; 72(5):1543-6. PubMed ID: 8348489
[TBL] [Abstract][Full Text] [Related]
10. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.
Ippoliti C; Champlin R; Bugazia N; Przepiorka D; Neumann J; Giralt S; Khouri I; Gajewski J
J Clin Oncol; 1997 Nov; 15(11):3350-4. PubMed ID: 9363865
[TBL] [Abstract][Full Text] [Related]
11. Octreotide acetate in refractory bone marrow transplant-associated diarrhea.
Crouch MA; Restino MS; Cruz JM; Perry JJ; Hurd DD
Ann Pharmacother; 1996 Apr; 30(4):331-6. PubMed ID: 8729883
[TBL] [Abstract][Full Text] [Related]
12. Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue.
Kreinik G; Burstein O; Landor M; Bernstein L; Weiss LM; Wittner M
AIDS; 1991 Jun; 5(6):765-7. PubMed ID: 1883548
[TBL] [Abstract][Full Text] [Related]
13. Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995.
Füessl HS; Zoller WG; Kochen MM; Bogner JR; Heinrich B; Matuschke A; Goebel FD
Klin Wochenschr; 1989 Apr; 67(8):452-5. PubMed ID: 2724869
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety.
Ho KY; Weissberger AJ; Marbach P; Lazarus L
Ann Intern Med; 1990 Feb; 112(3):173-81. PubMed ID: 2404445
[TBL] [Abstract][Full Text] [Related]
15. Long-acting octreotide in the treatment of diarrhea after pelvic pouch surgery.
Gullichsen R
Tech Coloproctol; 2006 Dec; 10(4):346-9. PubMed ID: 17115310
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.
Arnold R; Trautmann ME; Creutzfeldt W; Benning R; Benning M; Neuhaus C; Jürgensen R; Stein K; Schäfer H; Bruns C; Dennler HJ
Gut; 1996 Mar; 38(3):430-8. PubMed ID: 8675099
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea.
Walker JJ; Kaplan DS
Am J Gastroenterol; 1993 May; 88(5):765-7. PubMed ID: 8480746
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of octreotide LAR in the treatment of Crohn's disease associated refractory diarrhea.
Martelli L; Colard A; Fontaine F; Deflandre J; Bastens B; Louis E
Scand J Gastroenterol; 2017 May; 52(5):564-569. PubMed ID: 28270045
[TBL] [Abstract][Full Text] [Related]
19. Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study.
Van Assche G; Ferrante M; Vermeire S; Noman M; Rans K; Van der Biest L; Penninckx F; Wolthuis A; Rutgeerts P; D'Hoore A
Colorectal Dis; 2012 Apr; 14(4):e181-6. PubMed ID: 21951549
[TBL] [Abstract][Full Text] [Related]
20. Octreotide in the management of diarrhea induced by graft versus host disease.
Ippoliti C; Neumann J
Oncol Nurs Forum; 1998 Jun; 25(5):873-8. PubMed ID: 9644703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
